Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY-NC-NDTranslational Lung Cancer Research

Retrospective real-world associations between EGFR alterations and furmonertinib outcomes in advanced non-small cell lung cancer

  • Yameng Cui1
  • Shaozhang Zhou2
  • Zheng Liu3
  • Qichuan Wang4
  • Liuchun Wang5
  • Yanhong Shang6
  • Jinghao Jia7
  • Hongjiang Yu8
  • Jiangyan Zhang9
  • Zihui An10
  • Zhansheng Jiang1
  • Junli Cao10
10 affiliations
  1. 1Tianjin Medical University Cancer Institute and Hospital , National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer , Tianjin , ;
  2. 2Department of Respiratory Oncology , Guangxi Medical University Cancer Hospital , Nanning , ;
  3. 3Department of Oncology Three , Handan Central Hospital , Handan , ;
  4. 4Department of Lung Cancer , Nanyang Second General Hospital , Nanyang, ;
  5. 5Department of Pulmonary Medical Oncology , Tianjin Medical University Cancer Institute and Hospital , Tianjin , ;
  6. 6Department of Oncology, Affiliated Hospital of Hebei University , Baoding , ;
  7. 7Department of Oncology, Affiliated Hospital of North China University of Science and Technology , Tangshan , ;
  8. 8Department of Oncology , Tongliao City Hospital , Tongliao , ;
  9. 9Nanjing Geneseeq Technology Inc. , Nanjing , ;
  10. 10Department of Oncology , The First Hospital of Qinhuangdao , Qinhuangdao , ;
Read full textPDFCite

Related

  1. Triple Genetic Alterations (EGFR Mutation, ALK Fusion, and MET Polysomy) in Gynecological Metastasis of Lung Adenocarcinoma Patient with Acquired Resistance to Furmonertinib: A Case Report.
    Qinglong Jiang, Rui Sun, Haiyan Xu +1
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  2. Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP score ≥ 5%: results from the RATIONALE-305 trial
    Markus Moehler, Marcia Cruz Correa, Do Youn Oh +8
    Quality of Life ResearchPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMCEurope PMC
  3. Clinical Characteristics and Outcomes of Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Retrospective Cohort Study from an Integrated Advanced Lung Disease and Lung Transplant Program in the US
    Shambhu Aryal, Shourjo Chakravorty, Ho Cheol Kim +7
    Journal of clinical medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  4. Palliative Sedation at Home in Patients with Advanced Cancer: A Retrospective Observational Study of Clinical Characteristics and Sedation-Related Outcomes
    Salvador Martín Utrilla, Paula Oliver de Haro, Julián Mollá Marinas +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  5. Clinical outcomes of first-line nivolumab plus chemotherapy in patients aged ≥ 75 years with unresectable advanced or recurrent gastric cancer: a retrospective study.
    Masaki Yoshimatsu, Shinji Morita, Yu Ueta +10
    World journal of surgical oncologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{cui2026retrospective,
  title = {{Retrospective real-world associations between EGFR alterations and furmonertinib outcomes in advanced non-small cell lung cancer}},
  author = {Yameng Cui and Shaozhang Zhou and Zheng Liu and Qichuan Wang and Liuchun Wang and Yanhong Shang and Jinghao Jia and Hongjiang Yu and Jiangyan Zhang and Zihui An and Zhansheng Jiang and Junli Cao},
  journal = {Translational Lung Cancer Research},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13657901},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Retrospective real-world associations between EGFR alterations and furmonertinib outcomes in advanced non-small cell lung cancer
AU  - Yameng Cui
AU  - Shaozhang Zhou
AU  - Zheng Liu
AU  - Qichuan Wang
AU  - Liuchun Wang
AU  - Yanhong Shang
AU  - Jinghao Jia
AU  - Hongjiang Yu
AU  - Jiangyan Zhang
AU  - Zihui An
AU  - Zhansheng Jiang
AU  - Junli Cao
PY  - 2026
DA  - 2026/09/24
JO  - Translational Lung Cancer Research
UR  - https://europepmc.org/article/PMC/PMC13657901
SN  - 2218-6751
ER  -